|
|
 
 |
| ORIGINAL/BRIEF |
|
| Year : 2012 | Volume
: 4
| Issue : 5 | Page : 81-83 |
|
|
Formulation and kinetic modeling of curcumin loaded intranasal mucoadhesive microemulsion
B Mikesh Patel, Surjyanarayan Mandal, KS Rajesh
Parul Institute of Pharmacy, Limda, Vadodara, India
| Date of Web Publication | 21-Mar-2012 |
Correspondence Address:
B Mikesh Patel
Parul Institute of Pharmacy, Limda, Vadodara
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0975-7406.94148
 Abstract | | |
It is a challenge to develop the optimum dosage form of poorly water-soluble drugs and to target them due to limited bioavailability, intra and inter subject variability. In this investigation, mucoadhesive microemulsion of curcumin was developed by water titration method taking biocompatible components for intranasal delivery and was characterized. Nasal ciliotoxicity studies were carried out using excised sheep nasal mucosa. in vitro release studies of formulations and PDS were performed. Labrafil M 1944 CS based microemulsion was transparent, stable and nasal non-ciliotoxic having particle size 12.32±0.81nm (PdI=0.223) and from kinetic modeling, the release was found to be Fickian diffusion for mucoadhesive microemulsion. Keywords: Curcumin, intranasal, mucoadhesive microemulsion
How to cite this article:
Patel B M, Mandal S, Rajesh K S. Formulation and kinetic modeling of curcumin loaded intranasal mucoadhesive microemulsion. J Pharm Bioall Sci 2012;4, Suppl S1:81-3 |
How to cite this URL:
Patel B M, Mandal S, Rajesh K S. Formulation and kinetic modeling of curcumin loaded intranasal mucoadhesive microemulsion. J Pharm Bioall Sci [serial online] 2012 [cited 2022 Jul 6];4, Suppl S1:81-3. Available from: https://www.jpbsonline.org/text.asp?2012/4/5/81/94148 |
It is a challenge to develop the optimum dosage form of poorly water-soluble chemical entities and simultaneously to target these entities due to their low aqueous solubility followed by limited bioavailability, intra and inter subject variability. [1] To overcome such drawbacks, now various alternative strategies have been explored including nasal route and dosage forms like nanoparticles, emulsions, and solid dispersion etc. Microemulsions (ME) have attracted considerable amount of interest as potential drug delivery systems largely due to their simple method of preparation, stability, solubility enhancement and their abilities to incorporate a wide range of drugs of varying solubility which is expected to enhance the oral. Mucoadhesive microemulsion (MME) increases the residence time by minimizing the nasal drainage so facilitates the absorption process. [2] Curcumin is a water insoluble compound and being a non-invasive method, intranasal administration through microemulsion might be a feasible way of both accommodating relatively higher dose of Curcumin and enhancement of bioavailability.
| Materials and Methods | |  |
Materials
Curcumin was obtained as a gift sample from Amsar Pvt. Ltd., Goa. Capmul MCM, Accenon, Captex-355 were obtained from Abitec Corporation Ltd., Janeswille, USA. Labrafac, Labrasol, Tanscutol P and Labraphil were obtained from Gattefosse India Pvt. Ltd., Mumbai. Tween-80, Tween-60, Isopropyl myristate, Oleic acid and Soyabean oil were obtained from S.D. Fine Chemicals Ltd., Mumbai. Carbopol 934P was obtained from CDH, New Delhi.
Pseudo-ternary phase diagram
Pseudo-ternary phase diagrams were constructed to obtain the appropriate components and their concentration ranges that result in large existence area of microemulsion as shown in [Figure 1]. Different ME were prepared with suitable oil and different ratios of selected surfactant and cosurfactant (1:1, 2:1, 2.5:1, 3:1 and 3.5:1). | Figure 1: Pseudo-ternary phase diagram of microemulsion (a, 3:1 and b, 3.5:1 ratio of S: CoS)
Click here to view |
Preparation and characterization of microemulsion
Curcumin loaded Microemulsion was prepared by water titration method and was optimized through process and formulation optimization. Predetermined amount of the drug was dissolved in the required quantity of oil. Surfactant and cosurfactant in a fixed ratio were added to it. Finally the above mixture was titrated by distilled water with continuous stirring until a transparent and homogenous microemulsion was produced. Developed Microemulsion was characterized for its transparency, globule size and zeta potential, pH and % assay. Mucoadhesive gel of the microemulsion (MMEI) was prepared by using Carbopol P-934 and the gel was neutralized by dimethylamine.
Nasal ciliotoxicity study
Nasal ciliotoxicity studies were carried out using excised sheep nasal mucosa. Excise nasal mucosa was exposed with equal strength of MME, Saline (negative control) and Analgin (positive control) for 1 hr. The mucocilia was then examined with an optical microscope (Nikon Fx-35A, Japan).
In-vitro drug release studies
In vitro release studies of MME, ME and PDS were performed through sheep nasal mucosa using a modified Franz diffusion cell at 37±2°C. Then size of 2.4 nm of excised nasal mucosa was cut and mounted on the receptor compartment of Franz diffusion cell filled with phosphate buffer pH. 6.8 and at fixed time interval sample were withdrawn and analyzed spectrophotometrically at 420 nm. The release profile as shown in [Figure 2] was fitted into kinetic model to know the release profile as shown in [Table 2].
| Result and Discussion | | |
Result of the characterization was given in the [Table 1], [Table 2]. The value of polydispersity index (PI) of both cases were found to be below 1.0 (i.e., 0.223) suggesting that stability persists upon dilution. Aggregations will not take place due to slightly negative charge of the droplets leading to the stability of the formulation.
From the in-vitro release study it was found that mucoadhesive microemulsion (Batch M1) showed more sustained release which is shown in the [Figure 2]. Release data was fitted in to the kinetic models which indicate that the release profile is Fickian.
| Conclusion | | |
The studies demonstrated that Labrafil M 1944 CS based microemulsion system stabilized by Acenon CC and Transcutol P and mucoadhesive microemulsion system were optimal for intranasal delivery of Curcumin. However, clinical benefits to the risk ratio of the formulation developed in this investigation will decide its appropriateness in the clinical practice. [3]
| References | | |
| 1. | Merisko-Liversidge EM, Liversidge GG. Drug nanoparticles: Formulating poorly water-soluble compounds. Toxicol Pathol 2008;36:43-8. 
|
| 2. | Mandal S, Mandal SS. Design and development of carbamazepine mucoadhesive microemulsion for intranasal delivery: An ex-vivo study. Int J Pharma Sci Rev Res 2010;3:56-60.
|
| 3. | Illum L. Nasal drug delivery: Problems, possibilities and solutions. J Control Release 2003;87:187-98.
|
[Figure 1], [Figure 2]
[Table 1], [Table 2]
| This article has been cited by | | 1 |
Biochemical, Ameliorative and Cytotoxic Effects of Newly Synthesized Curcumin Microemulsions: Evidence from In Vitro and In Vivo Studies |
|
| Abbas Rahdar, Mohammad Reza Hajinezhad, Saman Sargazi, Maryam Zaboli, Mahmood Barani, Francesco Baino, Muhammad Bilal, Esmael Sanchooli | | Nanomaterials. 2021; 11(3): 817 | | [Pubmed] | [DOI] | | | 2 |
Odorranalectin modified PEG–PLGA/PEG–PBLG curcumin-loaded nanoparticle for intranasal administration |
|
| Xinrui Li, Jing Su, Zul Kamal, Pengcheng Guo, Xinyi Wu, Lina Lu, Hongbing Wu, Mingfeng Qiu | | Drug Development and Industrial Pharmacy. 2020; 46(6): 899 | | [Pubmed] | [DOI] | | | 3 |
Lethal Effect of Various Derivatives of Curcumin on Trichomonas vaginalis in vitro |
|
| MoradAli Fouladvand, Afshin Barazesh, Rahim Tahmasebi, Khosro Mohammadi, Soliman Khorami | | Iranian South Medical Journal. 2018; 21(2): 116 | | [Pubmed] | [DOI] | | | 4 |
Intranasal mucoadhesivemicroemulsion for neuroprotective effect of curcuminin mptp induced Parkinson model |
|
| Snigdha Das Mandal,Surjyanarayan Mandal,Jayvadan Patel | | Brazilian Journal of Pharmaceutical Sciences. 2017; 53(2) | | [Pubmed] | [DOI] | | | 5 |
Transnasomucosal mucoadhesive microemulsion of zaltoprofen: A comparative brain distribution study |
|
| Surjyanarayan Mandal,Snigdha Das Mandal,Krishna Chuttani,Abhay Dharamsi,Bharat bhushan Subudhi | | Journal of Drug Delivery Science and Technology. 2017; 39: 237 | | [Pubmed] | [DOI] | | | 6 |
Neuroprotective effect of ibuprofen by intranasal application of mucoadhesive nanoemulsion in MPTP induced Parkinson model |
|
| Surjyanarayan Mandal,Snigdha Das Mandal,Krishna Chuttani,Krutika K. Sawant,Bharat Bhushan Subudhi | | Journal of Pharmaceutical Investigation. 2016; 46(1): 41 | | [Pubmed] | [DOI] | | | 7 |
Brain targeting efficiency of Curcumin loaded mucoadhesive microemulsion through intranasal route |
|
| Snigdha Das Mandal,Surjyanarayan Mandal,Jayvadan Patel | | Journal of Pharmaceutical Investigation. 2016; | | [Pubmed] | [DOI] | | | 8 |
Analgesic and anti-inflammatory controlled-released injectable microemulsion: Pseudo-ternary phase diagrams, in vitro, ex vivo and in vivo evaluation |
|
| Isabel Pineros,Karla Slowing,Dolores R. Serrano,Esther de Pablo,Maria Paloma Ballesteros | | European Journal of Pharmaceutical Sciences. 2016; | | [Pubmed] | [DOI] | | | 9 |
Design and evaluation of mucoadhesive microemulsion for neuroprotective effect of ibuprofen following intranasal route in the MPTP mice model |
|
| Surjyanarayan Mandal,Snigdha Das Mandal,Krishna Chuttani,Krutika K Sawant,Bharat Bhushan Subudhi | | Drug Development and Industrial Pharmacy. 2016; : 1 | | [Pubmed] | [DOI] | | | 10 |
Mucoadhesive microemulsion of ibuprofen: design and evaluation for brain targeting efficiency through intranasal route |
|
| Surjyanarayan Mandal,Snigdha Das Mandal,Krishna Chuttani,Bharat Bhushan Subudhi | | Brazilian Journal of Pharmaceutical Sciences. 2015; 51(3): 721 | | [Pubmed] | [DOI] | | | 11 |
In vitro efficacy of curcumin on Trichomonas vaginalis |
|
| Benjamin Wachter,Michael Syrowatka,Andreas Obwaller,Julia Walochnik | | Wiener klinische Wochenschrift. 2014; | | [Pubmed] | [DOI] | | | 12 |
Self-Microemulsifying Drug Delivery System: Formulation and Study Intestinal Permeability of Ibuprofen in Rats |
|
| Bharat Bhushan Subudhi,Surjyanarayan Mandal | | Journal of Pharmaceutics. 2013; 2013: 1 | | [Pubmed] | [DOI] | | | 13 |
Curcumin (diferuloylmethane) delivery methods: A review |
|
| Helson, L. | | BioFactors. 2013; 39(1): 21-26 | | [Pubmed] | | | 14 |
Curcumin (diferuloylmethane) delivery methods: A review |
|
| Lawrence Helson | | BioFactors. 2013; 39(1): 21 | | [Pubmed] | [DOI] | |
|
 |
|
|
|
